DexCom Announces Upcoming Conference Presentations
February 22 2017 - 4:01PM
Business Wire
DexCom, Inc. (NASDAQ:DXCM) today announced that management will
present an update on DexCom at the following upcoming investor
conferences:
- Steven Pacelli, Executive Vice
President, Strategy and Corporate Development, will present an
update on the company at the Raymond James & Associates’ 38th
Annual Institutional Investors Conference in Orlando, Florida on
Monday, March 6, 2017 at 4:00pm (EST). The presentation, which will
occur live at the JW Marriott Grande Lakes Hotel, will be
concurrently webcast.
- Matthew Dolan, Senior Director
Corporate Affairs, will present an update on the company at the
Cowen and Company 37th Annual Health Care Conference in Boston,
Massachusetts on Tuesday, March 7, 2017 at 8:00am (EST). The
presentation, which will occur live at the Boston Marriott Copley
Place, will be concurrently webcast.
- Steven Pacelli, Executive Vice
President, Strategy and Corporate Development, will present an
update on the company at the Barclays Global Healthcare Conference
in Miami Beach, Florida on Thursday, March 16, 2017 at 8:30am
(EDT). The presentation, which will occur live at the Loews Miami
Beach Hotel, will be concurrently webcast.
- Steven Pacelli, Executive Vice
President, Strategy and Corporate Development, will present an
update on the company at the Oppenheimer 27th Annual Healthcare
Conference in New York City, New York on Tuesday, March 21, 2017 at
1:00pm (EDT). The presentation, which will occur live at the Westin
New York Grand Central Hotel, will be concurrently webcast.
The link to each webcast will be available on the DexCom website
at www.dexcom.com by navigating to “Our Company,” then “Investor
Relations,” and finally “Events and Webcasts” and will be archived
there for future reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is
developing and marketing continuous glucose monitoring systems for
ambulatory use by patients and by healthcare providers in the
hospital.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170222006255/en/
DexCom, Inc.Steven R. PacelliExecutive Vice President,
Strategy and Corporate Development(858) 200-0200
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Mar 2024 to Apr 2024
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Apr 2023 to Apr 2024